DEVELOPMENT OF A NOVEL DRUG-RELEASE SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .2. DESIGN OF MULTIPARTICULATE TES AND IN-VITRO DRUG-RELEASE PROPERTIES

被引:0
作者
UEDA, S [1 ]
YAMAGUCHI, H [1 ]
KOTANI, M [1 ]
KIMURA, S [1 ]
TOKUNAGA, Y [1 ]
KAGAYAMA, A [1 ]
HATA, T [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD, TECHNOL DEV LABS, YODOGAWA KU, OSAKA 532, JAPAN
关键词
TIME-CONTROLLED EXPLOSION SYSTEM (TES); MULTIPARTICULATE; SWELLING AGENT; SOLUBILITY; DRUG RELEASE; LAG TIME;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For the design of multiparticulate Time-Controlled Explosion System (TES), the thickness of the swelling agent layer was optimized by determining the amount of drug released. Low-substituted hydroxypropylcellulose (L-HPC) was used as a swelling agent. At 120 mu m thickness, tiapride hydrochloride was released before the membrane destruction, while at 180 mu m thickness the drug release was completed within 30 min after the destruction. Similar results were obtained for TES containing metoclopramide hydrochloride. These results suggest that the L-HPC layer must be at least 180 mu m thick. To evaluate the effect of solubility of the drug on release behavior, sodium diclofenac and nilvadipine were used as typical model drugs with an acidic functional group and poor solubility, respectively. The release studies were performed for these drugs in TES with 180 pm L-HPC layer. It is demonstrated that TES can provide a constant drug release profile, regardless of the solubility of a drug and dissolution conditions. In the case that L-HPC layer was fixed at a thickness of 180 mu m, the release of diclofenac was not influenced by drug content.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 9 条
[1]   PHYSICOCHEMICAL ASPECTS OF DRUG RELEASE .10. INVESTIGATION OF THE APPLICABILITY OF THE CUBE ROOT LAW FOR CHARACTERIZATION OF THE DISSOLUTION RATE OF FINE PARTICULATE MATERIALS [J].
ANDERBERG, EK ;
NYSTROM, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) :143-151
[2]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[3]  
HELLENBRECHT D, 1987, MED METHODS CLIN PHA, V7, P67
[4]   THE EFFECT OF PARTICLE-SIZE DISTRIBUTION ON DISSOLUTION RATE AND ORAL ABSORPTION [J].
HINTZ, RJ ;
JOHNSON, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :9-17
[5]   INVITRO RELEASE CHARACTERISTICS OF A MEMBRANE-COATED PELLET FORMULATION - INFLUENCE OF DRUG SOLUBILITY AND PARTICLE-SIZE [J].
RAGNARSSON, G ;
SANDBERG, A ;
JOHANSSON, MO ;
LINDSTEDT, B ;
SJOGREN, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 79 (2-3) :223-232
[6]   TOPOGRAPHICAL DISSOLUTION CHARACTERIZATION FOR CONTROLLED RELEASE PRODUCTS - A NEW TECHNIQUE [J].
SKELLY, JP ;
YAMAMOTO, LA ;
SHAH, VP ;
YAU, MK ;
BARR, WH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (8-9) :1159-1175
[7]   INVITRO TOPOGRAPHICAL CHARACTERIZATION AS A PREDICTOR OF INVIVO CONTROLLED RELEASE QUINIDINE GLUCONATE BIOAVAILABILITY [J].
SKELLY, JP ;
YAU, MK ;
ELKINS, JS ;
YAMAMOTO, LA ;
SHAH, VP ;
BARR, WH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (8-9) :1177-1201
[8]   RETARDATION OF WEAKLY BASIC DRUGS WITH DIFFUSION TABLETS [J].
THOMA, K ;
ZIMMER, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 58 (03) :197-202
[9]  
UEDA S, 1993, IN PRESS J DRUG TARG